NYSEMKT: ELMDElectromed Inc Stock
$14.50+0.56 (+4.02%)
Updated Apr 19, 2024
ELMD Price
$14.50
Fair Value Price
N/A
Market Cap
$124.78M
52 Week Low
$8.80
52 Week High
$17.85
P/E
30.85x
P/B
3.09x
P/S
1.8x
PEG
2.75x
Dividend Yield
N/A
Revenue
$51.69M
Earnings
$3.94M
Gross Margin
76.5%
Operating Margin
10.32%
Profit Margin
7.6%
Debt to Equity
0.16
Operating Cash Flow
$5M
Beta
0.68
Next Earnings
May 7, 2024
Ex-Dividend
N/A
Next Dividend
N/A
ELMD Overview
Electromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. The company is headquartered in New Prague, Minnesota and currently employs 119 full-time employees. The firm's products include the SmartVest Airway Clearance System (SmartVest System), the SmartVest SQL System and others. As of June 30, 2016, the SmartVest System is available in two models: SV2100 and SQL. The SmartVest System consists of an inflatable therapy garment, a programmable air pulse generator and a single-hose, which delivers air pulses from the generator to the garment. The SmartVest SQL System is small, quiet and light, and offers generator programmability. The firm markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to healthcare providers, particularly those working in intensive care units. The firm sells its products to the home healthcare market for patients with chronic lung issues, including bronchiectasis, cystic fibrosis and neuromuscular disease.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ELMD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ELMD ($14.50) is trading above its intrinsic value of $4.42, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ELMD is good value based on its earnings relative to its share price (30.85x), compared to the US market average (40.51x)
P/E vs Market Valuation
ELMD is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more ELMD due diligence checks available for Premium users.
Be the first to know about important ELMD news, forecast changes, insider trades & much more!
ELMD News
Valuation
ELMD price to earnings (PE)
For valuing profitable companies with steady earnings
Company
30.85x
Industry
28.69x
Market
40.51x
ELMD is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ELMD is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
ELMD price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.09x
Industry
3.63x
ELMD is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ELMD price to earnings growth (PEG)
For valuing profitable companies with growth potential
ELMD is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
ELMD's financial health
Profit margin
Revenue
$13.7M
Net Income
$1.7M
Profit Margin
12.2%
ELMD's Earnings (EBIT) of $5.34M... subscribe to Premium to read more.
Interest Coverage Financials
ELMD's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$47.0M
Liabilities
$6.6M
Debt to equity
0.16
ELMD's short-term assets ($39.27M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ELMD's short-term assets ($39.27M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ELMD's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ELMD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$3.5M
Investing
-$87.0k
Financing
$26.0k
ELMD's operating cash flow ($4.87M)... subscribe to Premium to read more.
Debt Coverage Financials
ELMD vs Medical Device Stocks
Electromed Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.